The PPRD score stratifies patients with hepatocellular carcinoma and portal vein tumor thrombus treated with sorafenib plus transarterial chemoembolization
Sign Up to like & getrecommendations! Published in 2020 at "European Radiology"
DOI: 10.1007/s00330-020-07078-z
Abstract: Objectives To identify clinical prognostic and predictive factors in patients with hepatocellular carcinoma (HCC) and portal vein tumor thrombus (PVTT) undergoing sorafenib plus transarterial chemoembolization (TACE) and establish a prognostic score for these patients. Methods… read more here.
Keywords: pprd score; group; sorafenib plus; score ... See more keywords
Irradiation stent with 125I plus tace versus sorafenib plus tace for hepatocellular carcinoma with major portal vein tumor thrombosis: a multicenter randomized trial.
Sign Up to like & getrecommendations! Published in 2023 at "International journal of surgery"
DOI: 10.1097/js9.0000000000000295
Abstract: BACKGROUND AND AIM Treatment strategy of hepatocellular carcinoma (HCC) and Vp4 [main trunk] portal vein tumor thrombosis (PVTT) remains limited due to post treatment liver failure. We aimed to assess the efficacy of irradiation stent… read more here.
Keywords: portal vein; tace; irradiation stent; sorafenib plus ... See more keywords